What We Do
Research at the Dementia Research Centre (Singapore) could potentially lead to the detection of blood-based biomarkers and neuroimaging tests for the early diagnosis of dementia, paving the way for potential new prevention therapies and treatments for Alzheimer’s disease and other related diseases of the brain.
The Biomarkers and Cognition Study, Singapore (BIOCIS) is a visionary prospective cohort study, established and led by the DRCS at Lee Kong Chian School of Medicine. We plan to identify biomarkers that contribute to the development of cognitive impairment. Our ultimate goal is to identify novel biomarkers to detect diseases that cause dementia at the earliest possible stage and to develop strategies which could potentially prevent and delay the development of dementia…
What We Offer
For Interested Participants
Participate In Our
- Register your interest by filling up the screening form
- DRCS will screen and determine eligibility
- If eligible, you will be contacted through email or whatsapp. Please note that we have a high volume of enquiries, so it will take some time. Thank you for your patience.
- Ensure that you are physically well before your appointment (i.e. No acute respiratory infection symptoms)
To participate, please click here.
You will receive
Brief report of cognitive, neuroimaging and essential blood tests.
Token of participation for completing each visit
Disclaimer - The report comprises of results from a research study. Results from the report does not replace medical or professional advice.